Canadian researchers are making groundbreaking discoveries about autoimmune diseases, particularly lupus, revealing how our immune system turns against us and what new treatments could revolutionize patient care.
An examination of racism within Canada's military challenges the 'systemic' label, arguing for a more nuanced understanding of institutional culture and individual accountability.
Canadian taxpayers have footed a $1.5 million bill as the federal government battles a class action lawsuit from Black public servants alleging workplace discrimination, raising questions about government accountability.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.